Title:
キナーゼ阻害のためのヘテロアリール化合物
Document Type and Number:
Japanese Patent JP7212733
Kind Code:
B2
Abstract:
Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFRand mutant HER2 activity, are described herein.
Inventors:
Wei-Sheng Huang
Gon Youngjin
Li Feng
Nicholas E. Bencivenga
David C. Dalgarno
Anna Coleman
William See. Shakespeare
Lanny M. Thomas
Angela buoy. Waist
Wilmen Youngsay
Zhang Yun
tianjun elephant
Xiaotian Zoo
Gon Youngjin
Li Feng
Nicholas E. Bencivenga
David C. Dalgarno
Anna Coleman
William See. Shakespeare
Lanny M. Thomas
Angela buoy. Waist
Wilmen Youngsay
Zhang Yun
tianjun elephant
Xiaotian Zoo
Application Number:
JP2021131767A
Publication Date:
January 25, 2023
Filing Date:
August 12, 2021
Export Citation:
Assignee:
Takeda GmbH
International Classes:
C07D401/14; C07D403/04; C07D405/14; C07D471/04
Domestic Patent References:
| JP2013544273A | ||||
| JP2012526113A | ||||
| JP2011526299A | ||||
| JP6230205B2 | ||||
| JP6546630B2 |
Foreign References:
| US20110263541 | ||||
| WO2013169401A1 | ||||
| WO2015195228A1 | ||||
| WO2015175632A1 |
Attorney, Agent or Firm:
Shusaku Yamamoto
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto